EOFY SALE: iBOTTLE+ NOW $199 — WAS $399. Ends June 30 · 30-day risk-free trial · Free shipping

Our Services

Web Design

Your content goes here. Edit or remove this text inline.

Logo Design

Your content goes here. Edit or remove this text inline.

Web Development

Your content goes here. Edit or remove this text inline.

VIEW ALL SERVICES

Shop Our Products

Hoodies

Your content goes here. Edit or remove this text inline.

T-Shirts

Your content goes here. Edit or remove this text inline.

Jeans

Your content goes here. Edit or remove this text inline.

BROWSE ALL OUR PRODUCTS

More of us

Customer Reviews

Your content goes here. Edit or remove this text inline.

Good Stuff We do!

Your content goes here. Edit or remove this text inline.

More From Us...

Your content goes here. Edit or remove this text inline.

EXPLORE CUSTOMERS STORIES

Discussion – 

0

Discussion – 

0

Coral calcium carried hydrogen ameliorates the severity of non-alcoholic steatohepatitis induced by a choline deficient high carbohydrate fat-free diet in elderly rats


Hydrogen Water Studies

Non-Alcoholic SteatohepatitisAging

Coral calcium carried hydrogen ameliorates the severity of non-alcoholic steatohepatitis induced by a choline deficient high carbohydrate fat-free diet in elderly rats

by Daisuke Ueda, Kuai Ma, Masayuki Fujino, Naotsugu Ichimaru, Neiki Nambu, Xiao-Kang Li, Xin Hu

Abstract:

Hydrogen has been reported to act as an antioxidant, anti-apoptosis and anti-inflammatory agent. Coral calcium carried hydrogen (G2-SUISO) is a safer and more convenient form of hydrogen agent than others. The mechanism underlying the hepatoprotective effects of G2-SUISO using an elderly non-alcoholic steatohepatitis (NASH) rat model was investigated. Two days after fasting, six-month-old elderly male F344/NSlc rats were given a choline deficient high carbohydrate fat-free (CDHCFF) diet from day 0 to day 3 as CDHCFF control group, and then switched to a normal diet from days 4 to 7 with or without 300 mg/kg G2-SUISO. Rats in each group were finally being sacrificed on day 3 or day 7. In the CDHCFF diet group, G2-SUISO decreased the liver weight-to-body weight ratio, the serum AST, ALT, total cholesterol levels, inflammatory infiltration, pro-inflammatory cytokine expression and lipid droplets with inhibiting lipogenic pathways by reducing sterol regulatory element-binding protein-1c, acetyl-CoA carboxylase and fatty acid synthase gene expression compared with the CDHCFF diet alone. G2-SUISO had beneficial effects of anti-apoptosis as well the down-regulation of pro-apoptotic molecules including NF-κB, caspase-3, caspase-9 and Bax. These findings suggest that G2-SUISO treatment exerts a significant hepatoprotective effect against steatosis, inflammation and apoptosis in elderly NASH rats.

Read more:

https://doi.org/10.1038/s41598-023-38856-6

Related Articles:

Sam Solomon

Research Scientist at iBottle

0 Comments

Submit a Comment

My cart
Your cart is empty.

Looks like you haven't made a choice yet.